🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 44 of 200 · A–Z by INN

  1. conbercept

    NMPA: clinical trials

  2. concentrate of proteolytic enzymes enriched in bromelain

    NEXOBRID

    EMA: approved

    D03BA03

  3. concizumab

    ALHEMO

    INJECTION FDA: approved · EMA: approved · PMDA: approved

    B02BX10

  4. concizumab-mtci

    ALHEMO

    SUBCUTANEOUS FDA: approved

  5. conestat alfa

    RUCONEST

    EMA: approved

    B06AC04

  6. conivaptan hydrochloride

    VAPRISOL CUMBERLAND PHARMACEUTICALS INC

    INJECTION FDA: approved

  7. conjugated estrogens/medroxyprogesterone acetate

    PREMPRO/PREMPHASE

    ORAL FDA: approved

  8. conscious

    NMPA: clinical trials

  9. consolidation

    NMPA: clinical trials

  10. control

    NMPA: clinical trials

  11. conventional

    NMPA: clinical trials

  12. copanlisib

    ALIQOPA

    EMA: application withdrawn

  13. copanlisib dihydrochloride

    ALIQOPA

    INTRAVENOUS FDA: approved

  14. copper

    PARAGARD T 380A

    INTRAUTERINE FDA: approved

  15. copper (64cu) chloride

    CUPRYMINA

    EMA: approved

    Not yet assigned

  16. copper (64cu) oxodotreotide

    DEQTYNET

    EMA: unknown

    V09IX15

  17. copper cu-64 dotatate

    DETECTNET

    INTRAVENOUS FDA: approved

  18. copper histidinate

    ZYCUBO

    SUBCUTANEOUS FDA: approved

  19. corifollitropin alfa

    ELONVA Organon Pharma Pty Ltd

    EMA: approved · TGA: approved

    G03GA09

  20. coronavac

    NMPA: clinical trials

  21. coronavirus (sars-cov-2) rna vaccine

    DAICHIRONA PARTIAL CHANGE APPROVAL

    PMDA: approved

  22. coronavirus (sars-cov-2) rna vaccine (active ingredient: mafb-7256a)

    DAICHIRONA (MONOVALENT, OMICRON XBB.1.5) PARTIAL CHANGE APPROVAL

    PMDA: approved

  23. coronavirus (sars-cov-2) rna vaccine (active ingredient: ufrenmeran)

    DAICHIRONA (MONOVALENT, ORIGINAL) INITIAL APPROVAL

    PMDA: approved

  24. coronavirus (sars-cov-2) rna vaccine (active ingredients of bivalent original/omicron ba.1 vaccine: elasomeran and imelasomeran) (active ingredients of bivalent original/omicron ba.4-5 vaccine: elasomeran and davesomeran) (active ingredient of monovalent

    SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) (BIVALENT, ORIGINAL/OMICRON BA.4-5) (MONOVALENT, OMICRON XBB.1.5) PARTIAL CHANGE APPROVAL

    PMDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources